UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000025614
Receipt number R000029464
Scientific Title Perampanel for sporadic amyotrophic lateral sclerosis (ALS): A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Trial
Date of disclosure of the study information 2017/02/01
Last modified on 2021/01/14 15:26:16

No. Disposal Last modified on Item of update
1 Insert 2017/01/11 09:50:24
2 Update 2017/01/11 13:46:13 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
3 Update 2017/01/11 13:49:49 Key inclusion criteria
4 Update 2017/01/12 16:58:46 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
5 Update 2017/04/25 14:14:54 Institutions
6 Update 2017/04/25 14:17:49 Recruitment status
Anticipated trial start date
7 Update 2017/07/13 16:20:15 Recruitment status
8 Update 2017/10/11 15:47:22 Institutions
9 Update 2017/10/13 08:58:11 Institutions
10 Update 2018/06/28 18:59:08 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
11 Update 2018/10/20 19:26:46 Recruitment status
12 Update 2018/12/06 16:07:13 Organization
Organization
Organization
Nationality of Funding Organization
13 Update 2018/12/06 16:25:19 Other related information
14 Update 2020/01/14 10:30:20 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Division name
Zip code
Address
Address

Last name of contact person

Last name of contact person
Division name
Zip code
Address
Address
Division name
Institute
Organization
Organization
Address
Address
Tel
Email
15 Update 2020/01/14 10:31:19 Number of participants that the trial has enrolled
16 Update 2020/01/14 10:35:25 Date of IRB
17 Update 2021/01/14 15:26:18 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded